Current Trials at TCTU

GREAT-2 is a clinical trial to test a new treatment for bronchiectasis. Full information can be found on our website.

In follow-up

The purpose of this study is to investigate how often different types of pneumonia occur in people admitted to hospital and how often an infection of a specific bacterium occurs.

Recruiting

This study is part of a major programme of research, called the Advanced Pain Discovery Platform - APDP. The programme is looking to understand the causes of chronic pain and improve the lives of people who have pain conditions

Recruiting

This study is part of a major programme of research, called the Advanced Pain Discovery Platform - APDP. The programme is looking to understand the causes of chronic pain and improve the lives of people who have pain conditions.

Recruiting

To determine if intravenous treatment with alpha-1 proteinase inhibitor reduces sputum neutrophil elastase activity in patients with bronchiectasis.

Recruiting

Pneumowave have designed a wearable respiratory monitoring device. This is worn by people who use drugs (PWUD) and connected to a blue tooth ‘hub’. The hub records their breathing patterns and can be used to detect events requiring an emergency response.

In set-up

Evaluation of a Community Pharmacy-Based Testing Method for People with Diabetes Compared to Standard Care Laboratory-Based Testing

In analysis

Developing strategies for Hepatitis C in Ethiopia.

Ongoing

Research to test the effectiveness of an inhaled antibiotic, Cayston, on bronchiectasis.

Recruiting

Evaluation of Hepatitis C treatments in NHS Tayside in order to empirically test the 'treatment as prevention' models.

In Analysis

Evaluating the population impact of Hepatitis C direct-acting antiviral treatment as prevention for people who inject drugs.

In Analysis

The SOPHIST trial studies the effect of the drug, Sotagliflozin, on the quality of life of individuals with Heart Failure and Type 1 Diabetes.

In set-up

This is an unblinded platform trial, investigating different anti-inflammatories for the treatment of bronchiectasis. This is part of the EMBARC research network.

In set-up